Deubiquitination of EGFR by Cezanne-1 contributes to cancer progression.

Pareja, F; Ferraro, D A; Rubin, C; Cohen-Dvashi, H; Zhang, F; Aulmann, S; Ben-Chetrit, N; Pines, G; Navon, R; Crosetto, N; Köstler, W; Carvalho, S; Lavi, S; Schmitt, F; Dikic, I; Yakhini, Z; Sinn, P; Mills, G B; Yarden, Y

Pareja, F; Ferraro, D A; Rubin, C; Cohen-Dvashi, H; Zhang, F; Aulmann, S; Ben-Chetrit, N; Pines, G; Navon, R; Crosetto, N; Köstler, W; Carvalho, S; Lavi, S; Schmitt, F; Dikic, I; Yakhini, Z; Sinn, P; Mills, G B; Yarden, Y.

Affiliation

Pareja F; Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel.

Oncogene ; 31(43): 4599-608, 2012 Oct 25.

Article in En | MEDLINE | ID: mdl-22179831

Subject(s)

Endopeptidases/metabolism; ErbB Receptors/metabolism; Neoplasms/pathology; Catalysis; Disease Progression; Humans; Neoplasms/metabolism; Phosphorylation; RNA, Small Interfering; Ubiquitin/metabolism; Ubiquitination

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Endopeptidases / ErbB Receptors / Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Oncogene Year: 2012 Document type: Article

Fulltext

XML

PubMed Links

Search on Google